Nā huahana
-
ʻO ka Hormone Hoʻoulu Follicle (FSH)
Hoʻohana ʻia kēia huahana no ka ʻike qualitative o ke kiʻekiʻe o ka Follicle Stimulating Hormone (FSH) i loko o ka mimi kanaka in vitro.
-
14 HPV Pilikia Ki'eki'e me 16/18 Genotyping
Hoʻohana ʻia ka pahu no ka ʻike PCR qualitative fluorescence-based o nā ʻāpana nucleic acid kikoʻī i nā ʻano papillomavirus 14 (HPV) kanaka (HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68) i loko o nā pūnaewele exfoliated cervical i loko o nā wahine, a me ka HPV 16/18 genotyping e kōkua i ka ʻike a mālama i ka maʻi HPV.
-
Helicobacter Pylori Antigen
Hoʻohana ʻia kēia kit no ka ʻike in vitro qualitative o Helicobacter pylori antigen i nā laʻana o ka waihona kanaka.ʻO nā hopena hōʻike no ka hōʻailona kōkua o ka maʻi Helicobacter pylori i loko o ka maʻi maʻi ʻōpū.
-
Pūʻulu A Rotavirus a me Adenovirus antigens
Hoʻohana ʻia kēia pahu no ka ʻike in vitro qualitative o ka hui A rotavirus a i ʻole adenovirus antigens i loko o nā laʻana o nā pēpē a me nā keiki liʻiliʻi.
-
ʻO Dengue NS1 Antigen, IgM/IgG Antibody Dual
Hoʻohana ʻia kēia pahu no ka ʻike in vitro qualitative o dengue NS1 antigen a me IgM/IgG antibody i loko o ka serum, plasma a me ke koko holoʻokoʻa e immunochromatography, ma ke ʻano he hōʻailona kōkua o ka maʻi maʻi dengue.
-
Luteinizing Hormone (LH)
Hoʻohana ʻia ka huahana no ka ʻike in vitro qualitative o ke kiʻekiʻe o ka hormone Luteinizing i ka mimi kanaka.
-
SARS-CoV-2 Nucleic Acid
Hoʻolālā ʻia ka pahu no In Vitro e ʻike pono ana i ka gene ORF1ab a me N gene o SARS-CoV-2 i ke ʻano o nā swabs pharyngeal mai nā hihia i manaʻo ʻia, nā mea maʻi me nā puʻupuʻu i manaʻo ʻia a i ʻole nā mea ʻē aʻe ma lalo o ka hoʻokolokolo ʻana i nā maʻi SARS-CoV-2.
-
ʻO SARS-CoV-2 Spike RBD Antibody
ʻO ka Enzyme-Linked Immunosorbent Assay no ka ʻike ʻana i ka SARS-CoV-2 Spike RBD Antibody i manaʻo ʻia e ʻike i ka valence o Antibody o SARS-CoV-2 Spike RBD Antigen i loko o ka serum/plasma mai ka heluna kanaka i hoʻopaʻa ʻia e ka kano SARS-CoV-2.
-
ʻO ka maʻi maʻi maʻi SARS-CoV-2 A influenza B Hui Pū ʻIa Nucleic
He kūpono kēia kit no ka ʻike in vitro qualitative o SARS-CoV-2, influenza A a me ka influenza B nucleic acid o ka nasopharyngeal swab a me nā oropharyngeal swab samples o ka poʻe i manaʻo ʻia i ka maʻi o SARS-CoV-2, influenza A a me ka influenza. B.
-
Nā ʻano like ʻole SARS-CoV-2
Hoʻolālā ʻia kēia pahu i ka ʻike in vitro qualitative o ka coronavirus novel (SARS-CoV-2) ma nā laʻana nasopharyngeal a me ka oropharyngeal swab samples.ʻIke ʻia ka RNA mai SARS-CoV-2 i nā ʻano hanu i ka wā o ka maʻi o ka maʻi a i ʻole ka poʻe asymptomatic.Hiki ke hoʻohana hou ʻia ka ʻike qualitative a me ka ʻokoʻa o Alpha, Beta, Gamma, Delta a me Omicron.
-
ʻO ka pahu RT-PCR fluorescent manawa maoli no ka ʻike ʻana iā SARS-CoV-2
Ua manaʻo ʻia kēia kit e ʻike pono i nā genes ORF1ab a me N o ka novel coronavirus (SARS-CoV-2) i loko o ka nasopharyngeal swab a me ka oropharyngeal swab i hōʻiliʻili ʻia mai nā hihia a me nā maʻi puʻupuʻu i manaʻo ʻia me ka novel coronavirus-infected pneumonia a me nā mea ʻē aʻe i koi ʻia no ka maʻi. a i ʻole ka maʻi ʻokoʻa o ka maʻi coronavirus hou.
-
SARS-CoV-2 IgM/IgG Antibody
Kuhi ʻia kēia kit no ka ʻike in vitro qualitative o SARS-CoV-2 IgG antibody i nā laʻana o ke kanaka o ka serum/plasma, ke koko venous a me ke koko manamana lima, e komo pū ana me SARS-CoV-2 IgG antibody i ka maʻi kūlohelohe a me ka maʻi kano.
